- $26.44bn
- $27.54bn
- $4.22bn
- 89
- 14
- 99
- 75
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,359 | 2,229 | 2,674 | 3,654 | 4,216 |
Cost of Revenue | |||||
Gross Profit | 1,929 | 1,682 | 1,940 | 2,838 | 3,363 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,646 | 3,010 | 3,820 | 3,889 | 3,976 |
Operating Profit | -287 | -780 | -1,147 | -236 | 240 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -332 | -901 | -1,321 | -265 | 297 |
Provision for Income Taxes | |||||
Net Income After Taxes | -337 | -908 | -1,339 | -278 | 264 |
Net Income Before Extraordinary Items | |||||
Net Income | -337 | -908 | -1,339 | -278 | 264 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -337 | -908 | -1,339 | -278 | 264 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.19 | -5.62 | -8.06 | -1.71 | 2.1 |